This dual mechanism of actionsuppressing appetite and slowing the emptying of food from the stomachmakes Semaglutide GLP-1 highly effective in aiding patients to adhere to a comprehensive medical weight management plan that includes dietary and exercise interventions

Product Attributes CAS # : 87616-84-0 Molecular Formula : C46H56N12O6 Sequence (AA) : HWAWFK-NH2 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) Molecular Weight : 873.0 g/mol PubChem CID : 4345065 Half-Life : ~15-60 minutes Synonyms : Growth Hormone Releasing Peptide-6, GHRP6, SKF-110679, Ghrelin Mimetic Hexapeptide Type : Synthetic research peptide (ghrelin receptor agonist / GH secretagogue) Research Focus : Growth Hormone & IGF-1, Recovery & Performance Scientific References Growth hormone-releasing peptide-6 stimulates GH secretion acting on the ghrelin receptor Animal | In vitro Ghrelin and growth hormone secretagogue receptor signaling in appetite and metabolism Animal | In vitro Effects of GHRP-6 on GH and prolactin secretion in healthy subjects Observational Cardioprotective effects of growth hormone-releasing peptides in experimental models Animal | In vitro GHRP-6 stimulates food intake and growth hormone release in rats Animal Growth hormone secretagogues: physiological role and clinical utility Observational | Animal GHRP-6 mechanism, research and effects overview Observational | Animal | In vitro Included In The Box Every product arrives in a premium, custom-designed PEPTIDE.Power box , engineered for convenience, hygiene, and safe storage in your refrigerator

In a Phase II trial of patients with metastatic pancreatic ductal adenocarcinoma (PDA) refractory to prior therapy, combination therapy with oral Entinostat (5 mg weekly) and intravenous Nivolumab (240 mg every 2 weeks) yielded partial responses in 11.1% (3/27) of patients, with response durations reaching 10.2 months
Check with your pharmacy to understand their shipping policies and costs